Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Stage III Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04285866
What this trial is testing

Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.

Who this might be right for
Small Cell Lung Cancer (SCLC)
Fundación GECP 245
Testing effectiveness (Phase 2)Study completedNCT01652820
What this trial is testing

Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer

Who this might be right for
Non Small-cell Lung Cancer
Spanish Lung Cancer Group 140
Large-scale testing (Phase 3)Not Yet RecruitingNCT07560358
What this trial is testing

Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 204
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06706219
What this trial is testing

Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer (Stage III)
Hunan Province Tumor Hospital 50
Not applicableLooking for participantsNCT06634199
What this trial is testing

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation
Fundación GECP 50
Testing effectiveness (Phase 2)Looking for participantsNCT07314216
What this trial is testing

Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)Stage IIIEGFR Uncommon Mutations
Hunan Cancer Hospital 15
Testing effectiveness (Phase 2)Study completedNCT04249362
What this trial is testing

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 102
Early research (Phase 1)Ended earlyNCT00356941
What this trial is testing

Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 4
Large-scale testing (Phase 3)Study completedNCT04513925
What this trial is testing

Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche 829
Testing effectiveness (Phase 2)UnknownNCT04580498
What this trial is testing

A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619911
What this trial is testing

SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
NSCLC Stage IIISHR-1701Chemoradiotherapy
Fudan University 84
Testing effectiveness (Phase 2)Ended earlyNCT06003075
What this trial is testing

Induction Chemo-Nivo in Unresectable Stage III NSCLC

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Stage III
Ralph G Zinner 1
Not applicableStudy completedNCT04229381
What this trial is testing

Resiliency Among Older Adults Receiving Lung Cancer Treatment

Who this might be right for
Advanced Lung CarcinomaExtensive Stage Lung Small Cell CarcinomaStage IIIA Lung Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 18
Large-scale testing (Phase 3)Ended earlyNCT00633568
What this trial is testing

Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Carcinoma
European Lung Cancer Working Party 125
Testing effectiveness (Phase 2)Study completedNCT04230408
What this trial is testing

Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers

Who this might be right for
Lung Neoplasms
Latin American Cooperative Oncology Group 48
Testing effectiveness (Phase 2)Ended earlyNCT00431613
What this trial is testing

Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 38
Testing effectiveness (Phase 2)Study completedNCT01733589
What this trial is testing

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Who this might be right for
Stage III Non-small-Cell Lung Cancer
Zhejiang Cancer Hospital 73
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Large-scale testing (Phase 3)Looking for participantsNCT07668752
What this trial is testing

Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation

Who this might be right for
KRAS G12D MutationNSCLC (Non-small Cell Lung Cancer)
Genfleet Therapeutics (Shanghai) Inc. 300
Next Page